C-reactive protein and cardiovascular risk: Has the time come for screening the general population?

Clinical Chemistry

Volumn 47, Issue 1, 2001, Pages 9-10

  Koenig, W ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; EDITORIAL; INFLAMMATION; RISK ASSESSMENT; SCREENING;

EID: 0035151682     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.1.9     Document Type: Editorial

References (15)

1. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses
2. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening
3. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
4. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
5. Clinical efficacy of an automated high-sensitivity C-reactive protein assay
6. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
7. Atherosclerosis - An inflammatory disease
8. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
9. C-reactive protein in the arterial intima. Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
10. Complement and atherogenesis: Binding of CRP to degraded, non-oxidized LDL enhances complement activation
11. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction
12. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease
13. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
14. Long-term effects of pravastatin on plasma concentration of C-reactive protein
15. Immunoradiometric assay of circulating C-reactive protein: Age-related values in the adult general population